.After antibody-drug conjugate (ADC) specialist Seagen was offered to Pfizer in 2014 for a whopping ...
.On the heels of a period 3 succeed that failed to excite clients, Ironwood Pharmaceuticals is back ...
.Do not quit Monte Rosa Therapeutics right now. The Boston-based biotech is enjoying after signing a...
.Accept to this week's Chutes & Ladders, our roundup of substantial leadership hirings, firings a...
.Celebrating his provider's upsized going public (IPO), Septerna chief executive officer Jeffrey Fin...
.AbbVie has come back to the resource of its own antipsychotic powerhouse Vraylar looking for one mo...
.GenSight Biologics is full weeks out of lacking amount of money. Again. The biotech only has enough...
.Monopar Rehabs is recouping a drug from the scrap heap of AstraZeneca's rare health condition pipel...
.With new data out on Arcus Biosciences' experimental HIF-2a prevention, one team of professionals f...
.After developing a gene treatment partnership with Dyno Therapies in 2020, Roche is actually back f...